Interestingly, MeCP2 has also been shown to modulate metabolic homeostasis, as observed in RTT patients and Mecp2-deficient mouse models exhibiting cholesterol- and mitochondrial-metabolism deficiencies [67,68,69,70]. This evidence concerns the gene MECP2 and Rett syndrome.